Skip to content

Acupuncture point implantable thread therapy for allergic rhinitis

Immunological Basis of Heterogeneous Nasal and Pulmonary Diseases Treated with a Common Approach and Mechanisms of Lingnan Herbal Interventions Based on Multi-Omics Big Data.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002616
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis

Interventions

True Thread Group:Oral loratadine: 10mg, once daily, for 3 consecutive days,And insert the empty buried thread needle into the corresponding acupoint, performing the same actions as the real buried th
Sham group:Oral loratadine: 10mg, once daily, for 3 consecutive days,And then bury the absorbable suture thread into the corresponding acupoints.

Sponsors

The People's Hospital of Suzhou New District
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18 and 65 years old; (2) Meet the diagnostic criteria for perennial allergic rhinitis; (3) Currently experiencing symptoms, able to accurately describe their condition, and willing to provide informed consent and participate in the clinical study. Allergic rhinitis (AR) patients are diagnosed based on the following criteria: (1) Symptoms: Two or more of the following symptoms occur: paroxysmal sneezing, clear rhinorrhea, nasal itching, and nasal congestion. Symptoms persist or accumulate for more than 1 hour per day, and may be accompanied by tearing, eye itching, and redness of the eyes; (2) Signs: Common signs include pale and edematous nasal mucosa, and clear secretions in the nasal cavity; (3) Allergen testing: At least one allergen shows positive results in SPT (skin prick test) and/or specific IgE in serum, or positive results in nasal provocation test.

Exclusion criteria

Exclusion criteria: (1) History of respiratory tract infection or acute sinusitis within the past 14 days; (2) Chest X-ray showing signs of inflammation; (3) History of chronic sinusitis or confirmed by X-ray examination; (4) Presence of organic nasal lesions or recent nasal surgery; (5) Diagnosed with asthma or other paroxysmal respiratory diseases; (6) Use of H1 antihistamines, steroids, decongestants, or other medications affecting the respiratory system within the past 14 days; (7) Received specific immunotherapy or systemic hormone therapy in the past year; (8) Undergone acupuncture, moxibustion, cupping, Chinese herbal nasal inhalation, or other traditional therapies within the past 14 days; (9) Contraindications (e.g., bleeding tendencies), mental disorders, pregnancy, or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Rhinitis Symptom Severity Scoring;Allergic Rhinitis and Conjunctivitis Quality of Life Questionnaire;

Secondary

MeasureTime frame
TCM syndrome score;

Countries

China

Contacts

Public ContactYing Yang

The People's Hospital of Suzhou New District

yangying771106@qq.com13881069520

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026